🌍·Sep 7, 2022Devices
Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay
Publisher
C
Chembio Diagnostics, Inc.
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Chembio Diagnostics, Inc.
- Region
- Global
- Scope
- Devices
- Published
- September 7, 2022
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on chembio.com
Leave the platform to read the original full article on the publisher site.
Source: Chembio Diagnostics, Inc.
Scope: Devices
Related coverage
More related coverage
American Society of Nephrology·20h ago
New nephSAP Issue: Electrolytes and Acid-Base Disorders
University of Freiburg·20h ago
EPICUR Seed Funding 2026 – submit your project ideas now
Erasmus University Rotterdam·20h ago
Tâm Ngô appointed as endowed professor of Historical Anthropology of War Legacies
University of Freiburg·20h ago